{"product_id":"global-diagnostic-radiopharmaceuticals-market-growth-2023-2029","title":"Global Diagnostic Radiopharmaceuticals Market Growth 2023-2029","description":"\u003cp\u003eGlobal Diagnostic Radiopharmaceuticals Market Growth 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eRadiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.\u003cbr\u003e\nLPI (LP Information)' newest research report, the “Diagnostic Radiopharmaceuticals Industry Forecast” looks at past sales and reviews total world Diagnostic Radiopharmaceuticals sales in 2022, providing a comprehensive analysis by region and market sector of projected Diagnostic Radiopharmaceuticals sales for 2023 through 2029. With Diagnostic Radiopharmaceuticals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diagnostic Radiopharmaceuticals industry.\u003cbr\u003e\nThis Insight Report provides a comprehensive analysis of the global Diagnostic Radiopharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Diagnostic Radiopharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Diagnostic Radiopharmaceuticals market.\u003cbr\u003e\nThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diagnostic Radiopharmaceuticals and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diagnostic Radiopharmaceuticals.\u003cbr\u003e\nThe global Diagnostic Radiopharmaceuticals market size is projected to grow from US$ 4289.7 million in 2022 to US$ 6959.8 million in 2029; it is expected to grow at a CAGR of 6959.8 from 2023 to 2029.\u003cbr\u003e\nNorth America is the world's major consumer region, with sales accounting for 41.59% of the global total in 2019. Europe is also a major consumer region, accounting for 24.5% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.\u003cbr\u003e\nThis report presents a comprehensive overview, market shares, and growth opportunities of Diagnostic Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.\u003cbr\u003e\nMarket Segmentation:\u003cbr\u003e\nSegmentation by type\u003cbr\u003e\n Technetium 99\u003cbr\u003e\n Fluorine 18\u003cbr\u003e\n Other\u003cbr\u003e\nSegmentation by application\u003cbr\u003e\n Oncology\u003cbr\u003e\n Cardiology\u003cbr\u003e\n Other\u003cbr\u003e\nThis report also splits the market by region:\u003cbr\u003e\n Americas\u003cbr\u003e\n United States\u003cbr\u003e\n Canada\u003cbr\u003e\n Mexico\u003cbr\u003e\n Brazil\u003cbr\u003e\n APAC\u003cbr\u003e\n China\u003cbr\u003e\n Japan\u003cbr\u003e\n Korea\u003cbr\u003e\n Southeast Asia\u003cbr\u003e\n India\u003cbr\u003e\n Australia\u003cbr\u003e\n Europe\u003cbr\u003e\n Germany\u003cbr\u003e\n France\u003cbr\u003e\n UK\u003cbr\u003e\n Italy\u003cbr\u003e\n Russia\u003cbr\u003e\n Middle East \u0026amp; Africa\u003cbr\u003e\n Egypt\u003cbr\u003e\n South Africa\u003cbr\u003e\n Israel\u003cbr\u003e\n Turkey\u003cbr\u003e\n GCC Countries\u003cbr\u003e\nThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\n Cardinal Health\u003cbr\u003e\n GE Healthcare\u003cbr\u003e\n Curium Pharma\u003cbr\u003e\n Jubilant Pharma\u003cbr\u003e\n Bracco Imaging\u003cbr\u003e\n Advanced Accelerator Applications\u003cbr\u003e\n SIEMENS\u003cbr\u003e\n China Isotope \u0026amp; Radiation\u003cbr\u003e\n Dongcheng Pharmaceutical Group\u003cbr\u003e\n Lantheus\u003cbr\u003e\n Eli Lilly\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Addressed in this Report\u003cbr\u003e\nWhat is the 10-year outlook for the global Diagnostic Radiopharmaceuticals market?\u003cbr\u003e\nWhat factors are driving Diagnostic Radiopharmaceuticals market growth, globally and by region?\u003cbr\u003e\nWhich technologies are poised for the fastest growth by market and region?\u003cbr\u003e\nHow do Diagnostic Radiopharmaceuticals market opportunities vary by end market size?\u003cbr\u003e\nHow does Diagnostic Radiopharmaceuticals break out type, application?\u003cbr\u003e\nWhat are the influences of COVID-19 and Russia-Ukraine war?\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 106 Pages \/ MCW16234647","offer_id":47650994913586,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-diagnostic-radiopharmaceuticals-market-growth-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}